Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.

Krichevsky, Anna M

Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. [electronic resource] - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 04 2019 - 319-347 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

1878-7479

10.1007/s13311-018-00702-3 doi


Animals
Brain Neoplasms--drug therapy
Glioblastoma--drug therapy
Humans
MicroRNAs--genetics
Molecular Targeted Therapy
Mutation
Oligonucleotides--therapeutic use
RNA, Long Noncoding--genetics